InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.53
(
-0.08%
)
Bitcoin
61,278.10
(
0.82%
)
Post# of 24568
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

SC 388

Send PM Follow Ignore
Followers 0
Posts 12
Boards Moderated 0
Alias Born 03/27/2010

SC 388

Re: colorofmoney post# 12856

Sunday, 02/27/2011 7:14:19 PM

Sunday, February 27, 2011 7:14:19 PM

Post# of 24568
XNPT: 3 near-term catalysts
(1) Arbaclofen Placarbil (AP) in patients with gastroesophageal reflux disease (GERD): Preliminary top-line results of Phase 2b in the 1st Qtr. '11
(2) Horizant: FDA PDUFA Date = 4/6/11 (GlaxoSmithKline)
(3) Horizant: PMDA in Japan (Astellas)
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up